Transmission scenarios for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and how to tell them apart - PubMed (original) (raw)
. 2013 Jun 13;18(24):20503.
Affiliations
- PMID: 23787162
- PMCID: PMC4088931
Transmission scenarios for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and how to tell them apart
S Cauchemez et al. Euro Surveill. 2013.
Abstract
Detection of human cases of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection internationally is a global public health concern. Rigorous risk assessment is particularly challenging in a context where surveillance may be subject to under-ascertainment and a selection bias towards more severe cases. We would like to assess whether the virus is capable of causing widespread human epidemics, and whether self-sustaining transmission is already under way. Here we review possible transmission scenarios for MERS-CoV and their implications for risk assessment and control. We discuss how existing data, future investigations and analyses may help in reducing uncertainty and refining the public health risk assessment and present analytical approaches that allow robust assessment of epidemiological characteristics, even from partial and biased surveillance data. Finally, we urge that adequate data be collected on future cases to permit rigorous assessment of the transmission characteristics and severity of MERS-CoV, and the public health threat it may pose. Going beyond minimal case reporting, open international collaboration, under the guidance of the World Health Organization and the International Health Regulations, will impact on how this potential epidemic unfolds and prospects for control.
Conflict of interest statement
Conflict of interest
SC received consulting fees from Sanofi Pasteur MSD for a project on the modelling of varicella zoster virus transmission. The authors declare no other competing interests.
Figures
Figure 1
Two illustrative scenarios for transmission of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) A. Few human-to-human infection events have occurred and observed clusters have arisen from separate spill-over events (i.e. introductions from the animal reservoir into human populations). B. Many undetected human-to human transmission events have occurred and the epidemic is already self-sustaining.
Figure 2
Probability that the epidemic of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection has become self-sustaining in humans after n introductions from the reservoir if _R_>1 R: reproduction number. This probability depends not only on R but also on the presence of super- spreading events (SSE) (without SSE: plain line; with SSE; dotted line). Values _R_=3 and _R_=1.2 were selected for illustrative purposes.
Figure 3
Upper bound for the reproduction number R as a function of the number of introductions from the reservoir that failed to generate self-sustaining epidemics
Similar articles
- Assessment of the Middle East respiratory syndrome coronavirus (MERS-CoV) epidemic in the Middle East and risk of international spread using a novel maximum likelihood analysis approach.
Poletto C, Pelat C, Levy-Bruhl D, Yazdanpanah Y, Boelle PY, Colizza V. Poletto C, et al. Euro Surveill. 2014 Jun 12;19(23):20824. doi: 10.2807/1560-7917.es2014.19.23.20824. Euro Surveill. 2014. PMID: 24957746 - Middle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibility.
Cauchemez S, Fraser C, Van Kerkhove MD, Donnelly CA, Riley S, Rambaut A, Enouf V, van der Werf S, Ferguson NM. Cauchemez S, et al. Lancet Infect Dis. 2014 Jan;14(1):50-56. doi: 10.1016/S1473-3099(13)70304-9. Epub 2013 Nov 13. Lancet Infect Dis. 2014. PMID: 24239323 Free PMC article. - Middle East respiratory syndrome coronavirus (MERS-CoV): challenges in identifying its source and controlling its spread.
Lu L, Liu Q, Du L, Jiang S. Lu L, et al. Microbes Infect. 2013 Jul-Aug;15(8-9):625-9. doi: 10.1016/j.micinf.2013.06.003. Epub 2013 Jun 19. Microbes Infect. 2013. PMID: 23791956 Free PMC article. Review. - A family cluster of Middle East Respiratory Syndrome Coronavirus infections related to a likely unrecognized asymptomatic or mild case.
Omrani AS, Matin MA, Haddad Q, Al-Nakhli D, Memish ZA, Albarrak AM. Omrani AS, et al. Int J Infect Dis. 2013 Sep;17(9):e668-72. doi: 10.1016/j.ijid.2013.07.001. Epub 2013 Aug 2. Int J Infect Dis. 2013. PMID: 23916548 Free PMC article. - Middle East respiratory syndrome coronavirus (MERS-CoV): what lessons can we learn?
Omrani AS, Shalhoub S. Omrani AS, et al. J Hosp Infect. 2015 Nov;91(3):188-96. doi: 10.1016/j.jhin.2015.08.002. Epub 2015 Aug 22. J Hosp Infect. 2015. PMID: 26452615 Free PMC article. Review.
Cited by
- Impact of proactive and reactive vaccination strategies for health-care workers against MERS-CoV: a mathematical modelling study.
Laydon DJ, Cauchemez S, Hinsley WR, Bhatt S, Ferguson NM. Laydon DJ, et al. Lancet Glob Health. 2023 May;11(5):e759-e769. doi: 10.1016/S2214-109X(23)00117-1. Lancet Glob Health. 2023. PMID: 37061313 Free PMC article. - In vitro Anti SARS-CoV-2 Activity and Docking Analysis of Pleurotus ostreatus, Lentinula edodes and Agaricus bisporus Edible Mushrooms.
Elhusseiny SM, El-Mahdy TS, Elleboudy NS, Yahia IS, Farag MMS, Ismail NSM, Yassien MA, Aboshanab KM. Elhusseiny SM, et al. Infect Drug Resist. 2022 Jul 2;15:3459-3475. doi: 10.2147/IDR.S362823. eCollection 2022. Infect Drug Resist. 2022. PMID: 35813084 Free PMC article. - Post-Covid-19 Rhino-Cerebral Mucormycosis: an Observational Study During the Second Wave.
Sajjan A, Nimbal AV, Shahapur R, Bagoji IB, Chiniwar VA, Chillalashetti SK. Sajjan A, et al. Maedica (Bucur). 2022 Mar;17(1):103-106. doi: 10.26574/maedica.2022.17.1.103. Maedica (Bucur). 2022. PMID: 35733739 Free PMC article. - Plant-Based Vaccines in Combat against Coronavirus Diseases.
Ortega-Berlanga B, Pniewski T. Ortega-Berlanga B, et al. Vaccines (Basel). 2022 Jan 18;10(2):138. doi: 10.3390/vaccines10020138. Vaccines (Basel). 2022. PMID: 35214597 Free PMC article. Review. - The transmission dynamics of Middle East Respiratory Syndrome coronavirus.
Rui J, Wang Q, Lv J, Zhao B, Hu Q, Du H, Gong W, Zhao Z, Xu J, Zhu Y, Liu X, Wang Y, Yang M, Luo L, Chen Q, Zhao B, Su Y, Cui JA, Chen T. Rui J, et al. Travel Med Infect Dis. 2022 Jan-Feb;45:102243. doi: 10.1016/j.tmaid.2021.102243. Epub 2021 Dec 22. Travel Med Infect Dis. 2022. PMID: 34954112 Free PMC article.
References
- World Health Organization (WHO) Coronavirus infections. Geneva: WHO; [Accessed 7 Jun 2013]]. Available from: http://www.who.int/csr/don/archive/disease/coronavirus_infections/en/ind....
- The Health Protection Agency (HPA) UK Novel Coronavirus Investigation team. Evidence of person-to-person transmission within a family cluster of novel coronavirus infections, United Kingdom February 2013. Euro Surveill. 2013;18(11) pii=20427. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20427. - PubMed
- Pebody R, Zambon M, Watson JM. Novel coronavirus: how much of a threat? We know the questions to ask; we don’t yet have many answers. BMJ. 2013;346:f1301. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources